Cis-imidazolines
US7425638B2 · kind B2 · utility
25Cited by
1References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 14, 2004 |
| Grant date | Sep 16, 2008 |
| Priority date | — |
| Expiry date | Jan 24, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/12
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention provides compounds according to formula Ihaving the designations provided herein, and pharmaceutically acceptable salts and esters thereof. These compounds inhibit the interaction of MDM2 protein with a p53-like peptide and have antiproliferative activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.